These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7058749)

  • 1. Failure of nifedipine therapy to reduce myocardial infarct size in the baboon.
    Geary GG; Smith GT; Suehiro GT; McNamara JJ
    Am J Cardiol; 1982 Feb; 49(2):331-8. PubMed ID: 7058749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative assessment in infarct size reduction by coronary venous retroperfusion in baboons.
    Geary GG; Smith GT; Suehiro GT; Zeman C; Siu B; McNamara JJ
    Am J Cardiol; 1982 Dec; 50(6):1424-30. PubMed ID: 7148722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative effect of early coronary artery reperfusion in baboons. Extent of salvage of the perfusion bed of an occluded artery.
    Geary GG; Smith GT; McNamara JJ
    Circulation; 1982 Aug; 66(2):391-6. PubMed ID: 7094245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction in infarct size by synchronized selective coronary venous retroperfusion of arterialized blood.
    Smith GT; Geary GG; Blanchard W; McNamara JJ
    Am J Cardiol; 1981 Dec; 48(6):1064-70. PubMed ID: 7304456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage of ischaemic myocardium by reperfusion: importance of collateral blood flow and myocardial oxygen demand during occlusion.
    Przyklenk K; Vivaldi MT; Schoen FJ; Malcolm J; Arnold O; Kloner RA
    Cardiovasc Res; 1986 Jun; 20(6):403-14. PubMed ID: 3779738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of perfluorocarbon exchange transfusion on reducing myocardial infarct size in a primate model of ischemia-reperfusion injury: a prospective, randomized study.
    Premaratne S; Harada RN; Chun P; Suehiro A; McNamara JJ
    Surgery; 1995 Jun; 117(6):670-6. PubMed ID: 7778030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High- and low-dose superoxide dismutase plus catalase does not reduce myocardial infarct size in a subhuman primate model.
    Watanabe BI; Premaratne S; Limm W; Mugiishi MM; McNamara JJ
    Am Heart J; 1993 Oct; 126(4):840-6. PubMed ID: 8213440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of early and late treatment with nifedipine during myocardial infarction in the conscious dog.
    Melin JA; Becker LC; Hutchins GM
    Circulation; 1984 Jan; 69(1):131-41. PubMed ID: 6689637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of mannitol to reduce myocardial infarct size in the baboon.
    Harada RN; Limm W; Piette LH; McNamara JJ
    Cardiovasc Res; 1992 Sep; 26(9):893-6. PubMed ID: 1451166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of nifedipine on acute experimental myocardial ischemia and infarction in dogs.
    Selwyn AP; Welman E; Fox K; Horlock P; Pratt T; Klein M
    Circ Res; 1979 Jan; 44(1):16-23. PubMed ID: 758229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nicorandil and nifedipine on protection of ischemic myocardium.
    Lamping KA; Christensen CW; Pelc LR; Warltier DC; Gross GJ
    J Cardiovasc Pharmacol; 1984; 6(3):536-42. PubMed ID: 6202983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Verapamil in two reperfusion models of myocardial infarction. Temporary protection of severely ischemic myocardium without limitation of ultimate infarct size.
    Reimer KA; Jennings RB
    Lab Invest; 1984 Dec; 51(6):655-66. PubMed ID: 6503220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood flow to infarct and surviving myocardium: implications regarding the action of verapamil on the acutely ischemic dog heart.
    Davenport N; Goldstein RE; Bolli R; Epstein SE
    J Am Coll Cardiol; 1984 Apr; 3(4):956-65. PubMed ID: 6707360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hyaluronidase on reducing myocardial infarct size in a baboon model of ischemia-reperfusion injury.
    Premaratne S; Watanabe BI; LaPenna WF; McNamara JJ
    J Surg Res; 1995 Feb; 58(2):205-10. PubMed ID: 7861774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of human recombinant superoxide dismutase on canine myocardial infarction.
    Patel BS; Jeroudi MO; O'Neill PG; Roberts R; Bolli R
    Am J Physiol; 1990 Feb; 258(2 Pt 2):H369-80. PubMed ID: 2309904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of nicardipine, a new calcium antagonist, on size of myocardial infarction after coronary artery occlusion in dogs.
    Endo T; Nejima J; Fujita S; Kiuchi K; Iida N; Kikuchi K; Hayakawa H; Okumura H
    Circulation; 1986 Aug; 74(2):420-30. PubMed ID: 3731430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of myocardial infarct size by the calcium antagonist fr 7534.
    Meils CM; Gross GJ; Brooks HL; Warltier DC
    Cardiology; 1981; 68(3):146-60. PubMed ID: 7317884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innate protection of baboon myocardium: effects of coronary artery occlusion and reperfusion.
    Shen YT; Fallon JT; Iwase M; Vatner SF
    Am J Physiol; 1996 May; 270(5 Pt 2):H1812-8. PubMed ID: 8928890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nifedipine limits infarct size for 24 hours in closed chest coronary embolized dogs.
    Yoshida S; Downey JM; Friedman FR; Chambers DE; Hearse DJ; Yellon DM
    Basic Res Cardiol; 1985; 80(1):76-87. PubMed ID: 3985927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicardipine in models of myocardial infarction.
    Alps BJ; Calder C; Wilson A
    Br J Clin Pharmacol; 1985; 20 Suppl 1(Suppl 1):29S-49S. PubMed ID: 4027150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.